Physician profile
Jonathan Farrell
NPI 1144831520
$4,362.85
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,598 · 2023: $2,665 · 2024: $99.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,883 · Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,882.97 |
| Food and Beverage | $881.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,366.86 | 2023 | Proclaim |
| Relievant Medsystems, INC. | $1,156.77 | 2023 | Intracept |
| Nevro Corp. | $1,136.20 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $156.83 | 2022 | |
| Radius Health, INC. | $152.68 | 2022-2023 | Tymlos |
| Collegium Pharmaceutical, INC. | $126.46 | 2022 | |
| Pfizer INC. | $70.83 | 2023 | |
| Abbvie INC. | $61.98 | 2023-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.85 | 2022 | |
| Averitas Pharma INC. | $46.72 | 2024 | Qutenza |
| Organon LLC | $19.08 | 2024 | |
| Nalu Medical, INC. | $14.59 | 2023 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Farrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.